Old Web
English
Sign In
Acemap
>
authorDetail
>
Nina Kishore
Nina Kishore
Boston Medical Center
Biomarker (medicine)
Placebo-controlled study
Medicine
Immunology
Wnt signaling pathway
2
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
2018
Clinical and Experimental Rheumatology
Julio C. Mantero
Nina Kishore
Jessica Ziemek
Giuseppina Stifano
Christopher Zammitti
Dinesh Khanna
Jessica K. Gordon
Robert Spiera
Yuqing Zhang
Robert W. Simms
Robert Lafyatis
Show All
Source
Cite
Save
Citations (18)
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
2017
Journal of Investigative Dermatology
Robert Lafyatis
Julio C. Mantero
Jessica K. Gordon
Nina Kishore
Mary Carns
Howard C. Dittrich
Robert Spiera
Robert W. Simms
John Varga
Show All
Source
Cite
Save
Citations (32)
1